av/torrent-pharmaceuticals--big.svg

NSE:TORNTPHARM

Torrent Pharmaceuticals Limited

  • Stock

INR

Last Close

2,630.65

15/05 10:00

Market Cap

825.10B

Beta: 0.23

Volume Today

98.91K

Avg: 264.27K

PE Ratio

59.48

PFCF: -

Dividend Yield

0.30%

Payout:0%

Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
9.65B
-
10.37B
7.43%
12.13B
16.97%
14.59B
20.29%
17.63B
20.85%
19.51B
10.67%
20.42B
4.66%
24.15B
18.27%
25.72B
6.50%
23.46B
8.77%
average payables
12.78B
-
16.64B
30.23%
20.97B
26.06%
23.16B
10.43%
21.73B
6.18%
20.72B
4.63%
20.87B
0.69%
20.72B
0.72%
18.71B
9.71%
16.77B
10.37%
average receivables
11.96B
-
17.85B
49.28%
20.12B
12.66%
9.47B
52.90%
9.67B
-
9.67B
0%
8.26B
14.66%
17.30B
109.47%
18.77B
8.52%
book value per share
56.21
-
73.59
30.91%
100.13
36.07%
128.53
28.36%
136.57
6.25%
139.59
2.21%
142.51
2.09%
172.47
21.02%
175.89
1.98%
183.15
4.13%
capex per share
-11.82
-
-7.17
39.37%
-17.85
149.01%
-14.38
19.41%
-23.38
62.54%
-19.58
16.23%
-12.02
38.63%
-9.90
17.61%
-5.99
39.56%
-16.96
183.39%
capex to depreciation
-4.60
-
-1.27
72.35%
-2.45
93.03%
-1.59
35.39%
-1.94
22.09%
-1.07
44.59%
-0.62
42.07%
-0.51
18.04%
-0.31
39.94%
-0.81
165.30%
capex to operating cash flow
-0.67
-
-0.30
55.14%
-0.22
25.64%
-0.48
115.93%
-0.88
84.08%
-0.37
58.34%
-0.29
20.71%
-0.17
42.97%
-0.11
32.60%
-0.24
115.75%
capex to revenue
-0.10
-
-0.05
46.61%
-0.09
74.89%
-0.09
7.37%
-0.14
57.40%
-0.09
34.24%
-0.05
41.14%
-0.04
18.72%
-0.02
43.38%
-0.06
152.06%
cash per share
28.19
-
25.51
9.52%
41.52
62.78%
50.05
20.55%
40.17
19.74%
34.49
14.13%
19.57
43.26%
21.81
11.43%
17.22
21.01%
24.67
43.25%
days of inventory on hand
282.37
-
264.16
6.45%
300.77
13.86%
301.33
0.19%
403.92
34.05%
304.23
24.68%
348.10
14.42%
437.81
25.77%
354.19
19.10%
297.61
15.98%
days payables outstanding
411.83
-
460.46
11.81%
517.02
12.28%
444.10
14.10%
420.76
5.26%
329.64
21.66%
336.54
2.09%
337.49
0.28%
240.86
28.63%
224.07
6.97%
days sales outstanding
130.59
-
169.65
29.90%
106.09
37.46%
94.65
-
76.43
-
78.37
2.55%
75.05
4.24%
debt to assets
0.22
-
0.35
55.17%
0.26
24.24%
0.25
5.53%
0.45
83.01%
0.43
5.76%
0.42
2.71%
0.35
16.76%
0.31
10.29%
0.36
15.10%
debt to equity
0.59
-
1.10
84.95%
0.70
36.57%
0.58
17.32%
1.40
142.30%
1.28
8.58%
1.21
5.26%
0.84
31.04%
0.68
18.13%
0.87
26.69%
dividend yield
0.03
-
0.01
66.21%
0.04
263.51%
0.01
79.06%
0.01
59.39%
0.01
22.04%
0.02
123.55%
0.01
63.51%
0.01
82.31%
0.02
15.80%
earnings yield
0.07
-
0.04
48.82%
0.08
98.28%
0.04
53.21%
0.03
10.94%
0.01
57.12%
0.03
126.32%
0.03
5.35%
0.02
43.41%
0.02
45.50%
enterprise value
92.35B
-
217.81B
135.85%
244.01B
12.03%
285.05B
16.82%
276.51B
3.00%
376.01B
35.99%
385.46B
2.51%
473.70B
22.89%
509.17B
7.49%
568.78B
11.71%
enterprise value over ebitda
9.64
-
17.16
78.08%
8.48
50.58%
18.54
118.62%
17.37
6.28%
18.79
8.14%
17.03
9.33%
18.76
10.14%
19.47
3.77%
19.70
1.20%
ev to operating cash flow
15.41
-
26.88
74.49%
8.99
66.55%
28.15
212.98%
30.92
9.86%
20.91
32.37%
27.69
32.44%
23.56
14.93%
28.24
19.87%
24.02
14.95%
ev to sales
2.29
-
4.76
107.70%
3.74
21.32%
5.03
34.27%
4.72
6.06%
5.04
6.74%
4.95
1.68%
6.01
21.24%
6.05
0.69%
6.01
0.63%
free cash flow per share
5.89
-
16.77
184.75%
62.32
271.58%
15.54
75.07%
3.04
80.43%
33.54
1,002.93%
29.10
13.23%
49.51
70.10%
47.29
4.48%
53.01
12.11%
free cash flow yield
0.02
-
0.03
28.85%
0.09
221.22%
0.02
78.48%
0.00
76.00%
0.04
635.12%
0.03
16.40%
0.04
31.79%
0.03
12.93%
0.03
1.81%
graham net net
-18.55
-
-71.72
286.55%
-62.60
12.70%
-97.53
55.79%
-215.04
120.48%
-171.68
20.16%
-220.96
28.70%
-145.38
34.20%
-117.51
19.17%
-159.70
35.91%
graham number
157.51
-
191.67
21.69%
338.61
76.66%
282.44
16.59%
248.13
12.15%
201.21
18.91%
311.58
54.85%
378.87
21.59%
301.46
20.43%
389.37
29.16%
income quality
0.71
-
0.86
21.38%
1.15
33.15%
0.93
18.92%
0.96
3.19%
3.20
233.32%
1.17
63.36%
1.32
12.31%
1.47
11.64%
1.28
12.83%
intangibles to total assets
0.01
-
0.24
4,179.16%
0.21
13.83%
0.18
13.79%
0.40
121.50%
0.36
9.41%
0.34
6.72%
0.31
8.51%
0.29
5.47%
0.36
24.44%
interest coverage
27.82
-
5.32
80.88%
13.86
160.58%
5.34
61.47%
3.09
42.22%
2.73
11.50%
3.59
31.36%
5.24
46.13%
7.72
47.32%
6.55
15.24%
interest debt per share
34.45
-
85.58
148.39%
75.24
12.08%
80.16
6.55%
199.95
149.43%
193.21
3.37%
185.80
3.84%
154.54
16.83%
127.72
17.35%
168.47
31.90%
inventory turnover
1.29
-
1.38
6.89%
1.21
12.17%
1.21
0.19%
0.90
25.40%
1.20
32.77%
1.05
12.60%
0.83
20.49%
1.03
23.61%
1.23
19.01%
invested capital
0.59
-
1.10
84.95%
0.70
36.57%
0.58
17.32%
1.40
142.30%
1.28
8.58%
1.21
5.26%
0.84
31.04%
0.68
18.13%
0.87
26.69%
market cap
88.72B
-
196.06B
121.00%
226.80B
15.68%
262.74B
15.84%
214.29B
18.44%
321.51B
50.03%
333.67B
3.78%
430.68B
29.07%
472.46B
9.70%
520.18B
10.10%
net current asset value
2.38B
-
-13.61B
673.22%
-9.62B
29.35%
-3.90B
59.43%
-43.58B
1,016.71%
-43.59B
0.02%
-42.06B
3.52%
-27.16B
35.42%
-19.82B
27.03%
-35B
76.60%
net debt to ebitda
0.38
-
1.71
351.90%
0.60
65.11%
1.45
142.68%
3.91
169.41%
2.72
30.35%
2.29
15.96%
1.70
25.55%
1.40
17.60%
1.68
19.93%
net income per share
19.62
-
22.19
13.11%
50.89
129.36%
27.58
45.80%
20.04
27.36%
12.89
35.66%
30.28
134.88%
36.99
22.17%
22.96
37.92%
36.79
60.21%
operating cash flow per share
17.71
-
23.94
35.16%
80.17
234.88%
29.92
62.68%
26.42
11.70%
53.13
101.09%
41.12
22.60%
59.41
44.47%
53.27
10.33%
69.97
31.35%
payables turnover
0.89
-
0.79
10.56%
0.71
10.94%
0.82
16.42%
0.87
5.55%
1.11
27.64%
1.08
2.05%
1.08
0.28%
1.52
40.12%
1.63
7.49%
receivables turnover
2.79
-
2.15
23.02%
3.44
59.91%
3.86
-
4.78
-
4.66
2.48%
4.86
4.43%
research and ddevelopement to revenue
0.00
-
0.00
24.18%
0.00
36.92%
0.01
-
0.00
73.15%
0.00
43.78%
0.00
28.03%
return on tangible assets
0.13
-
0.13
4.96%
0.24
92.82%
0.11
53.44%
0.08
29.68%
0.05
38.90%
0.11
127.66%
0.13
16.82%
0.08
34.88%
0.13
55.34%
revenue per share
119.14
-
135.29
13.55%
192.63
42.38%
167.59
13.00%
173.06
3.26%
220.47
27.39%
229.87
4.26%
233.01
1.37%
248.75
6.75%
279.66
12.43%
roe
0.35
-
0.30
13.60%
0.51
68.56%
0.21
57.77%
0.15
31.64%
0.09
37.05%
0.21
130.06%
0.21
0.95%
0.13
39.13%
0.20
53.86%
roic
0.25
-
0.13
48.69%
0.32
150.84%
0.14
57.35%
0.06
54.40%
0.10
59.82%
0.13
31.19%
0.14
9.83%
0.12
13.63%
0.13
2.71%
sales general and administrative to revenue
0.04
-
0.05
20.16%
0.03
29.99%
0.08
142.25%
0.10
24.76%
0.08
18.02%
0.08
4.71%
0.07
5.76%
0.07
10.29%
0.06
1.60%
shareholders equity per share
56.21
-
73.59
30.91%
100.13
36.07%
128.53
28.36%
136.57
6.25%
139.59
2.21%
142.51
2.09%
172.47
21.02%
175.89
1.98%
183.15
4.13%
stock based compensation to revenue
tangible asset value
18.74B
-
5.80B
69.06%
15.13B
160.92%
25.34B
67.43%
-10.39B
141.01%
-3.60B
65.30%
1.08B
129.98%
15.12B
1,298.75%
21.47B
42.03%
7.71B
64.10%
tangible book value per share
55.38
-
17.14
69.06%
44.71
160.92%
74.86
67.43%
-30.70
141.01%
-10.65
65.30%
3.19
129.98%
44.67
1,298.75%
63.45
42.03%
22.78
64.09%
working capital
12.30B
-
12.28B
0.18%
13.78B
12.24%
22.23B
61.33%
601.50M
97.29%
-1.28B
312.44%
-4.73B
270.36%
6.30B
233.10%
7.50B
19.05%
-1.33B
117.74%

All numbers in INR (except ratios and percentages)